The PCR/DCE-based heteroduplex method (heteroduplex analysis after the amplification of the mutated tumor-specific gene fragment) was used to detect mutations in genes commonly altered in lung cancer, e.g., EGFR, KRAS, TP53, PIK3CA, and BRAF. This evidence concerns the gene BRAF and lung carcinoma.